
Opinion|Videos|June 28, 2024
Surgical Considerations and Patient Selection for PDS With Ranibizumab
Author(s)Margaret A. Chang, MD, MS
Dr. Margaret Chang details the facility requirements for PDS implantation, the specialized training surgeons need, and crucial factors to consider for the surgical implantation of PDS.
Advertisement
Episodes in this series
- What facilities are required to implant the device, and what specific training does a surgeon need?
- What are the key considerations for the surgical implantation and subsequent refilling of the PDS?
- What are the major adverse effects associated with the PDS, and which patients are not suitable candidates for this delivery system?
- How does the PDS with ranibizumab fit into the treatment landscape that also includes highly durable agents such as faricimab and high-dose aflibercept?
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Ophthalmology Times - Clinical Insights for Eye Specialists
1
ARPA-H funds tear-duct biosensor system for dry eye, systemic disease
2
Memento Medicines launches with $93 million Series A to advance Tie2-activating bispecific for retinal disease
3
DSLT for glaucoma and ocular hypertension: Real-world outcomes in 218 eyes
4
First patient dosed in phase 3 pivotal cohort of LIGHTHOUSE trial evaluating ATSN-201 for X-linked retinoschisis
5


























